Human Reproduction, Vol. 11, No. 12, pp. 2581-2584, 1996
© 1996 European Society of Human Reproduction and Embryology
research-article |
Endocrinology: Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome
Reproductive Medicine Unit, Department of Obstetrics-Gynaecology, Jean Verdier Hospital Avenue du 14 juillet, Bondy 93143, France 1St Antoine Clinic Bois-Guillaume 76230, France
Correspondence: 2To whom correspondence should be addressed
This study was designed to compare both the effectiveness and safety of two low-dose gonadotrophin regimens (step-up versus sequential step-up and step-down) for ovulation induction in polycystic ovarian syndrome (PCOS) patients. In all, 56 infertile clomiphene citrate-resistant PCOS patients were included in this prospective randomized study. A total of 38 cycles were conducted with a classic step-up protocol, whereas for 35 cycles the follicle-stimulating hormone (FSH) threshold dose was reduced by half when the leading follicle reached 14 mm in diameter (sequential protocol). Serum oestradiol, progesterone and luteinizing hormone concentrations and follicular growth rate were evaluated during the cycle. At the time of human chorionic gonadotrophin administration, cycles treated with sequential protocol exhibited significantly lower oestradiol concentrations [434 ± 45 versus 593 ± 67 pg/ml (mean ± SEM)] and the number of medium-sized (1415 mm) follicles was significantly reduced (0.3 ± 0.1 versus 0.8 ± 0.2) compared with cycles treated with the classic step-up protocol. Moreover, in these cycles serum luteal oestradiol concentrations were decreased significantly (350 ± 77 versus 657 ± 104 pg/ ml) compared with the classic step-up protocol. A sequential step-up and step-down protocol seems to be a safe and effective regimen for ovulation induction in PCOS patients. Decreasing the FSH dose following step-up follicular selection may be an alternative method to avoid multifollicular development.
Key words: gonadotrophin therapy/ovarian hyperstimulation syndrome/polycystic ovarian syndrome/spontaneous abortion rate
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. R Eckmann and D. R Kockler Aromatase Inhibitors for Ovulation and Pregnancy in Polycystic Ovary Syndrome Ann. Pharmacother., July 1, 2009; 43(7): 1338 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consens Consensus on infertility treatment related to polycystic ovary syndrome Hum. Reprod., March 1, 2008; 23(3): 462 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cedrin-Durnerin, N. Massin, J. Galey-Fontaine, H. Bry-Gauillard, M. Roger, N. Lahlou, and J.N. Hugues Timing of FSH administration for ovarian stimulation in normo-ovulatory women: comparison of an early or a mid follicular phase initiation of a short-term treatment Hum. Reprod., November 1, 2006; 21(11): 2941 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.N. Hugues, I. Cedrin-Durnerin, C.M. Howles, and On Behalf of the Recombinant FSH OI Study Group The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study Hum. Reprod., November 1, 2006; 21(11): 2817 - 2822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dias, R. McNamee, and A. Vail Evidence of improving quality of reporting of randomized controlled trials in subfertility Hum. Reprod., October 1, 2006; 21(10): 2617 - 2627. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Christin-Maitre, J.N. Hugues, and on behalf of the Recombinant FSH Study Group A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome Hum. Reprod., August 1, 2003; 18(8): 1626 - 1631. [Abstract] [Full Text] [PDF] |
||||

